Medilinks Inc is involved in marketing specialized Oncology Genomics, Genetics & CTC testing for Breast, Colon, Prostate & Thyroid cancer for various multinational companies in India for the last 9 years.
Medilinks Inc is the sole representative in India of Genomic Health Inc., USA for the Oncotype DX Breast Recurrence Score® Test (the 21 Gene Expression Assay used in the TAILORx trial).
Breakthrough finding by the landmark Trial Assigning Individualized Options for Treatment (TAILORx) demonstrates the Oncotype DX Breast Recurrence Score® Test definitively identifies the 70% of women with early-stage breast cancer who receive no benefit from chemotherapy, and the 30% ... (more)
